Name | Haloxazolam |
Synonyms | CS-430 Haloxazolam 2-fluorophenyl)- azepin-6(5h)-one 10-bromo-11b-(2-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo(3,2-d)(1,4)benzodi 10-Bromo-11b-(2-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d](1,4)benzodiazepin-6(5H)-one 10-Bromo-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one 10-Bromo-11b-(2-fluorophenyl)-2,3,7,11b-tetrahydro[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one |
CAS | 59128-97-1 |
InChI | InChI=1/C17H14BrFN2O2/c18-11-5-6-15-13(9-11)17(12-3-1-2-4-14(12)19)21(7-8-23-17)10-16(22)20-15/h1-6,9H,7-8,10H2,(H,20,22) |
Molecular Formula | C17H14BrFN2O2 |
Molar Mass | 377.21 |
Density | 1.4808 (estimate) |
Melting Point | 185° |
Boling Point | 204°C (rough estimate) |
Flash Point | 260.3°C |
Vapor Presure | 2.15E-10mmHg at 25°C |
pKa | 12.66±0.40(Predicted) |
Refractive Index | 1.691 |
UN IDs | 3249 |
Hazard Class | 6.1(b) |
Packing Group | III |
Toxicity | LD50 in mice: 1850 mg/kg orally (Kamioka) |